missing translation for 'onlineSavingsMsg'
Learn More

Thermo Scientific Chemicals SB 203580, 98 %

Product Code. 15474079
missing translation for 'orderingAttributeHoverText'
Menge:
25 mg
50 mg
100 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Hochspezifischer neuer Inhibitor von p38-Kinase- und MAP-Kinase-Homologen

Highly specific new inhibitor of p38 kinase and MAP Kinase homologues

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

TRUSTED_SUSTAINABILITY

Chemical Identifiers

CAS 152121-47-6
Summenformel C21H16FN3OS
Synonym 4-(4-Fluorphenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)imidazol

Specifications

Menge 100 mg
Beschreibung Weißer bis weißgrau
Inhalt und Lagerung -30°bis -10 °C
Zur Verwendung mit (Anwendung) Hochspezifischer neuer Inhibitor von p38-Kinase- und MAP-Kinase-Homologen
Formelmasse 377,44g/mol
Schmelzpunkt 235°bis 247 °C
Produkttyp Signaltransduktionsreagenz
Form Pulver
InChI-Schlüssel CDMGBJANTYXAIV-UHFFFAOYNA-N
SMILES CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1
IUPAC-Name 4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine
Molekulargewicht (g/mol) 377.44
Assay 98%
Show More Show Less

RUO – Research Use Only

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.